Yuvraj

Norton Healthcare is one of first in nation to develop new convalescent plasma study for COVID-19 patients

Norton Healthcare is one of the first in the nation to study convalescent plasma as a therapy to prevent high-risk patients with COVID-19, the...

Amedisys Expands Personal Care Network with BrightStar Care

Amedisys, Inc., America’s leading independent home health, hospice and personal care company, has signed a Care Coordination Agreement with BrightStar Care to add its...

Massachusetts General Hospital researchers create bioluminescent tag to detect DNA break repair

A new bioluminescent reporter that tracks DNA double stranded break (DSB) repair in cells has been developed by researchers from Massachusetts General Hospital (MGH)...

Penn Medicine health system gets $2.5M to study RPM’s effect on COVID-19 disparities

Penn Medicine’s COVID Watch team has received a $2.5 million grant from the Patient-Centered Outcomes Research Institute (PCORI) to study the program’s impact, particularly...

LumiraDx gets FDA EUA status for point-of-care Covid-19 antigen test

LumiraDx has secured emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its point-of-care Covid-19 antigen test. LumiraDx SARS-CoV-2 antigen test...

AXIM Biotechnologies, Empowered Diagnostics collaborate on Covid-19 rapid neutralising antibody test

AXIM Biotechnologies has entered into an exclusive limited licencing, manufacturing and distribution agreement with Empowered Diagnostics on the Covid-19 rapid neutralising antibody test. The deal...

Medtronic Evolut TAVR System Receives Updated U.S. Labeling Revising Precaution for Treatment of Low-Risk Patients with Bicuspid Aortic Stenosis

Medtronic plc, the global leader in medical technology, announced the U.S. FDA has approved revised commercial labeling for the Evolut™ TAVR platform that modified...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read